Natural Killer Cells in Older Patients With Acute Myeloid Leukemia

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

RATIONALE: Studying natural killer cells in samples of blood from patients with cancer may help doctors find out how these cells are effected by chemotherapy.

PURPOSE: This clinical trial is studying natural killer cells in older patients with acute myeloid leukemia.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Institut Paoli-Calmettes
• Treatments: Cytarabine

Criteria

DISEASE CHARACTERISTICS:

• Diagnosis of acute myeloid leukemia

• No promyelocytic leukemia

• No prior therapy

PATIENT CHARACTERISTICS:

• Hemoglobin > 10 g/dL

PRIOR CONCURRENT THERAPY:

• See Disease Characteristics